INNOVATE Corp.
5.26+0.03 (+0.57%)
Oct 29, 4:00:02 PM EDT · NYSE · VATE · USD
Key Stats
Market Cap
70.15MP/E (TTM)
-Basic EPS (TTM)
-6.29Dividend Yield
0%Recent Filings
8-K
MediBeacon wins China approval
INNOVATE's equity method investment MediBeacon secured NMPA approval on October 21, 2025, for its Transdermal GFR System, including Lumitrace injection, enabling sales in China by year-end. This first-in-kind point-of-care kidney function tool targets the 11% CKD prevalence among China's 1.4 billion population, bolstered by a 2019 partnership with Huadong Medicine. China unlocks major growth. Yet risks like product misuse and IP protection loom.
8-K
DBM Global dividend payout
INNOVATE Corp. announced on October 16, 2025, that its portfolio company DBM Global will distribute a cash dividend of $8.8 million, or $2.28 per share, on November 10 to stockholders of record as of October 27. As DBMG's largest shareholder, INNOVATE anticipates receiving about $8 million, bolstering its liquidity. Individual INNOVATE stockholders won't get a cut. This payout underscores DBMG's solid performance amid steel construction demands.
8-K
R2's 88% revenue surge
INNOVATE's portfolio company R2 Technologies reported explosive Q2 2025 growth, with revenue up 88% and global system sales surging 125% year-over-year, driven by Glacial Skin's demand in North America and 768% international expansion over six months. Patient treatments rose 115%, while digital engagement outperformed benchmarks by 823%, boosting provider adoption and market share. R2's momentum positions it to capture rising non-invasive aesthetics demand. Yet risks like customer demand fluctuations loom.
8-K
Q2 revenue dips, backlog holds
INNOVATE Corp. reported Q2 2025 revenue of $242 million, down 22.7% year-over-year, mainly from Infrastructure's project timing, while Life Sciences surged 88% to $3.2 million on R2's unit sales growth. Adjusted EBITDA fell to $15.7 million, yet a $1.3 billion backlog signals steady demand. Refinancing closed August 4 extends debt maturities, easing near-term pressure. Spectrum eyes datacasting upside.
10-Q
Q2 FY2025 results
Innovate Corp's 10-Q filing for the quarter ended June 30, 2025, lacks the required financial statements and MD&A details, so key metrics like revenue, EPS, and cash flows cannot be analyzed from the provided document. Without access to the consolidated statements or notes, year-over-year and quarter-over-quarter changes remain undisclosed. The filing confirms the company's status as a non-accelerated filer and smaller reporting company, with 13,336,149 common shares outstanding as of August 1, 2025. Non-GAAP metrics are not disclosed in the 10-Q. Liquidity and debt details are absent. Competition from larger players poses ongoing challenges.
IPO
Website
Employees
Sector
Industry
GVA
Granite Construction Incorporat
103.15-0.62
IESC
IES Holdings, Inc.
417.99+7.37
INHD
Inno Holdings Inc.
1.10+0.02
LGN
Legence Corp.
41.54+1.94
MTZ
MasTec, Inc.
221.36+9.32
PRIM
Primoris Services Corporation
144.26+3.33
PWR
Quanta Services, Inc.
448.69+9.12
SHIM
Shimmick Corporation
2.32-0.03
STN
Stantec Inc
112.94-0.76
VMI
Valmont Industries, Inc.
419.23+1.84